Carpenter TO - Search Results

1

Burosumab for the Treatment of Tumor-Induced Osteomalacia.

Jan de Beur SM, Miller PD, Weber TJ, Peacock M, Insogna K, Kumar R, Rauch F, Luca D, Cimms T, Roberts MS, San Martin J, Carpenter TO. Jan de Beur SM, et al. Among authors: carpenter to. J Bone Miner Res. 2021 Apr;36(4):627-635. doi: 10.1002/jbmr.4233. Epub 2021 Jan 12. J Bone Miner Res. 2021. PMID: 33338281 Free PMC article. Clinical Trial.

2

A prospective trial of phosphate and 1,25-dihydroxyvitamin D3 therapy in symptomatic adults with X-linked hypophosphatemic rickets.

Sullivan W, Carpenter T, Glorieux F, Travers R, Insogna K. Sullivan W, et al. J Clin Endocrinol Metab. 1992 Sep;75(3):879-85. doi: 10.1210/jcem.75.3.1517380. J Clin Endocrinol Metab. 1992. PMID: 1517380

3

Vitamin D metabolism in chronic childhood hypoparathyroidism: evidence for a direct regulatory effect of calcium.

Carpenter TO, Insogna KL, Boulware SD, Mitnick MA. Carpenter TO, et al. J Pediatr. 1990 Feb;116(2):252-7. doi: 10.1016/s0022-3476(05)82883-5. J Pediatr. 1990. PMID: 2299496 Free article.

4

Nocturnal hyperparathyroidism: a frequent feature of X-linked hypophosphatemia.

Carpenter TO, Mitnick MA, Ellison A, Smith C, Insogna KL. Carpenter TO, et al. J Clin Endocrinol Metab. 1994 Jun;78(6):1378-83. doi: 10.1210/jcem.78.6.8200940. J Clin Endocrinol Metab. 1994. PMID: 8200940

5

Multisystem study of 20 older adults with Williams syndrome.

Cherniske EM, Carpenter TO, Klaiman C, Young E, Bregman J, Insogna K, Schultz RT, Pober BR. Cherniske EM, et al. Among authors: carpenter to. Am J Med Genet A. 2004 Dec 15;131(3):255-64. doi: 10.1002/ajmg.a.30400. Am J Med Genet A. 2004. PMID: 15534874

6

Fibroblast growth factor 7: an inhibitor of phosphate transport derived from oncogenic osteomalacia-causing tumors.

Carpenter TO, Ellis BK, Insogna KL, Philbrick WM, Sterpka J, Shimkets R. Carpenter TO, et al. J Clin Endocrinol Metab. 2005 Feb;90(2):1012-20. doi: 10.1210/jc.2004-0357. Epub 2004 Nov 23. J Clin Endocrinol Metab. 2005. PMID: 15562028

7

Survey of the enthesopathy of X-linked hypophosphatemia and its characterization in Hyp mice.

Liang G, Katz LD, Insogna KL, Carpenter TO, Macica CM. Liang G, et al. Among authors: carpenter to. Calcif Tissue Int. 2009 Sep;85(3):235-46. doi: 10.1007/s00223-009-9270-6. Epub 2009 Jul 17. Calcif Tissue Int. 2009. PMID: 19609735 Free PMC article.

8

Circulating levels of soluble klotho and FGF23 in X-linked hypophosphatemia: circadian variance, effects of treatment, and relationship to parathyroid status.

Carpenter TO, Insogna KL, Zhang JH, Ellis B, Nieman S, Simpson C, Olear E, Gundberg CM. Carpenter TO, et al. J Clin Endocrinol Metab. 2010 Nov;95(11):E352-7. doi: 10.1210/jc.2010-0589. Epub 2010 Aug 4. J Clin Endocrinol Metab. 2010. PMID: 20685863 Free PMC article.

9

Calcitonin administration in X-linked hypophosphatemia.

Liu ES, Carpenter TO, Gundberg CM, Simpson CA, Insogna KL. Liu ES, et al. Among authors: carpenter to. N Engl J Med. 2011 Apr 28;364(17):1678-80. doi: 10.1056/NEJMc1010928. N Engl J Med. 2011. PMID: 21524226 Free PMC article. No abstract available.

10

A clinician's guide to X-linked hypophosphatemia.

Carpenter TO, Imel EA, Holm IA, Jan de Beur SM, Insogna KL. Carpenter TO, et al. J Bone Miner Res. 2011 Jul;26(7):1381-8. doi: 10.1002/jbmr.340. Epub 2011 May 2. J Bone Miner Res. 2011. PMID: 21538511 Free PMC article. Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

164 results

Search Page